Consequently, UPLC-Q-TOF MS/MS analysis found a total of 55 divergent metabolites, 42 in serum samples and 13 in liver samples, and classified them as possible biomarkers linked with AKT/c-Met-induced HCC. Here, MET is linked to hepatocellular carcinoma.